|Articles|June 27, 2023
Opioid Reformulation for Abuse Deterrence - Filed as a CMC Supplement in Less Than a Year
Author(s)Societal CDMO
It is no secret that Opioid abuse is an ongoing public health emergency. Societal™’s client stood at an impasse in pursuit of providing pain relief to patients, while following the recommendation of the FDA to reformulate the product for abuse deterrence.
Related Content
Trending on Pharmaceutical Technology
1
European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized
2
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
3
Technology Transfer: Success Drivers and Obstacles Explained
4
Why Oral Solid Dosage Validation Is a Business Continuity Function, Not Just a Compliance Requirement
5